about
Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch.Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1).Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.Multiple verrucous lesions of the feet in Waldenström macroglobulinaemia.Case of psoriatic arthritis mutilans whose finger dysfunction was successfully ameliorated by surgical intervention during infliximab treatment.Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities.Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy.Relationship between environmental factors, age of onset and familial history in Japanese patients with psoriasisInterleukin-17A suppresses granular layer formation in a 3-D human epidermis model through regulation of terminal differentiation genesChild case of linear variant of telangiectasia macularis eruptiva perstansRelationship between the efficacy of biologics and clinical plaque psoriasis subtypes in Japanese patients: A single-center pilot studyEfficacy and Safety of the Traditional Japanese Medicine Keigairengyoto in the Treatment of Acne VulgarisCross-sectional multicenter observational study of psoriatic arthritis in Japanese patients: Relationship between skin and joint symptoms and results of treatment with tumor necrosis factor-α inhibitorsCholinergic urticaria with hypohidrosis successfully treated with omalizumabMycobacterium tuberculosis infection in psoriatic patients treated with biologics: Real-world data from 18 Japanese facilitiesTwenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativaPrevalence of inflammatory bowel disease in Japanese psoriatic patientsDistribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1Sustainability and switching of biologics for psoriasis and psoriatic arthritis at Fukuoka University Psoriasis RegistryJapanese guidance for use of biologics for psoriasis (the 2019 version)Body mass index in psoriatic patients with or without familial psoriasisRisk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014
P50
Q38764424-86E863FD-9C43-497D-B216-296F18129F8FQ40133568-0F81E0CA-2F3A-41F4-8755-306AF0427928Q40164166-0C91DC78-B1DF-45B1-89ED-94BA72150D8BQ47193581-4C2D9D6B-2A97-4654-AE75-D0189C6F5FB4Q48152575-F2DD87CA-9E0D-449F-862E-F5148B31C29FQ48167668-71186C4B-07EE-451C-848F-190316A736BCQ48197805-A6546ABF-AB65-4360-90B3-413BB787B61BQ64883748-82C327B5-4A12-418F-ADBB-8C64B617451DQ88251422-FF2C4DC2-C09C-4B22-9D70-457FC91C2B0EQ89534991-A0633AFA-3B57-492D-AB16-D2FE126138DEQ90156550-ADF446C3-ED90-4195-AFBB-B75FAED0B3C7Q90297743-AC0D6B52-04F0-4971-835B-BF308967B839Q90599541-13AC653F-8E81-4257-972F-579625169FB0Q90976275-CD7CAD6E-B38C-494B-8170-3BFB8E12CC4DQ90994502-25345D8C-A617-4112-A663-ECB258844315Q91432035-4F2B5E33-615E-4D49-86B0-456A2577A4BFQ91695235-A6CC182D-D181-4637-9096-73A1A901520DQ92009649-4DE5B2D0-F69C-477B-9DA5-4CE1952A2168Q92065345-3D1EAFD7-A46C-4912-8280-0591499BC704Q92300850-4A63CF52-D76C-4CC7-B22E-E82C0209A774Q92509421-CDBEE898-E487-4812-ABCC-978952A547BEQ92742958-3A2B63C3-0D8A-4DD8-A256-2B2B4E94D6BEQ92742986-4C43ACF1-4958-4A66-9AF3-0E0AFA3D8EDF
P50
description
researcher
@en
wetenschapper
@nl
name
Shinichi Imafuku
@en
Shinichi Imafuku
@nl
type
label
Shinichi Imafuku
@en
Shinichi Imafuku
@nl
prefLabel
Shinichi Imafuku
@en
Shinichi Imafuku
@nl
P31
P496
0000-0001-8568-4349